BioNTech SE (BNTX) Divestments (2019 - 2025)

BioNTech SE (BNTX) reported Divestments of -$1.1 billion for Q3 2025, down 593.16% on a YoY basis from $219.3 million in Q3 2024, and down 1383.89% sequentially from -$72.9 million in Q2 2025.

BioNTech SE (BNTX) Divestments (2019 - 2025) Analysis & Trends

BioNTech SE (BNTX) has 7 years of Divestments data on file, last reported at -$1.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -32.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 BioNTech SE 22.13 Bn 22.13 Bn 668.28 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.08 Bn
Jun 30, 2025 -72.90 Mn
Mar 31, 2025 1.31 Bn
Sep 30, 2024 -156.06 Mn
Jun 30, 2024 -259.96 Mn
Mar 31, 2024 -2.50 Bn
Sep 30, 2023 -1.34 Bn
Jun 30, 2023 -2.50 Bn
Mar 31, 2023 -789.34 Mn
Jun 30, 2022 -83.66 Mn
Mar 31, 2022 322.56 Mn
Sep 30, 2021 1.72 Bn
Jun 30, 2021 -35.89 Mn
Sep 30, 2020 487.56 Mn
Jun 30, 2020 -10.79 Mn
Mar 31, 2020 -16.49 Mn
Mar 31, 2019 -37.70 Mn